Thirty-two patients (64%) showed higher expression of UBQLN4 in CRC tissues than in matched ANTs (Fig. 1C), and UBQLN4 expression increased as the tumor progressed (Fig. 1D). This evidence concerns the gene UBQLN4 and colorectal carcinoma.